57 related articles for article (PubMed ID: 21207845)
1. [Study on the mechanism of how vasonatrin peptide can attenuate the growth-promoting effect of hypoxia in cardiac fibroblasts].
Yu J; Zhu MZ; Cheng BY; Lu SY; Dong MQ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Feb; 19(1):8-11. PubMed ID: 21207845
[TBL] [Abstract][Full Text] [Related]
2. [Vasonatrin peptide attenuates hypoxia-induced increase in [Ca(2+)] (i) of culured rat cardiac fibroblasts].
Guo HT; Zhu MZ; Lu SY; Yu J; Dong MQ; Gao Z; Shi PT
Sheng Li Xue Bao; 2001 Aug; 53(4):286-90. PubMed ID: 11930207
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes].
Lu SY; Zhu MZ; Guo HT; Yu J; Wei QM
Sheng Li Xue Bao; 2002 Feb; 54(1):7-11. PubMed ID: 11930233
[TBL] [Abstract][Full Text] [Related]
5. [Vasonatrin peptide attenuates the enhancement of electrically-induced intracellular calcium transient by isoproterenol in rat cardiac myocytes].
Guo HT; Zhu MZ; Zhang RH; Bi H; Zhang B; Zhang HF; Yu J; Lu SY; Pei JM
Sheng Li Xue Bao; 2004 Jun; 56(3):335-40. PubMed ID: 15224146
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells.
Lu SY; Wang DS; Zhu MZ; Zhang QH; Hu YZ; Pei JM
Life Sci; 2005 May; 77(1):28-38. PubMed ID: 15848216
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
8. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.
Chen BY; Qu P; Tie R; Zhu MZ; Zhu XX; Yu J
Regul Pept; 2010 Sep; 164(2-3):139-43. PubMed ID: 20619296
[TBL] [Abstract][Full Text] [Related]
9. Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.
Shi Z; Fu F; Yu L; Xing W; Su F; Liang X; Tie R; Ji L; Zhu M; Yu J; Zhang H
Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H281-90. PubMed ID: 25485902
[TBL] [Abstract][Full Text] [Related]
10. [Effect of vasonatrin peptide on the Ca2+ activated K+ channels of vascular smooth muscle cells isolated from rat mesentery arteries].
Yu J; Zhu MZ; Liu LB; Chen BY; Lu SY; Zhou JJ; Fu ZJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):94-7. PubMed ID: 21186590
[TBL] [Abstract][Full Text] [Related]
11. [Effect of vasonatrin peptide on the expression of C-type natriuretic peptide receptor in hypoxic rat hearts].
Yu J; Zhu MZ; Chen BY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Nov; 18(4):350-3. PubMed ID: 21174811
[TBL] [Abstract][Full Text] [Related]
12. Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy.
Chang P; Zhang X; Chen W; Zhang J; Wang J; Wang X; Yu J; Zhu X
Peptides; 2021 Mar; 137():170474. PubMed ID: 33359394
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats].
Dong MQ; Zhu MZ; Yu J; Shang LJ; Feng HS
Sheng Li Xue Bao; 2000 Jun; 52(3):252-4. PubMed ID: 11956575
[TBL] [Abstract][Full Text] [Related]
14. [Vasorelaxing role of vasonatrin peptide in human intramammary artery in vitro].
Yu J; Zhu MZ; Wei GZ; Chen BY; Lu SY; Kang YF; Guo HT; Ma H; Dong MQ
Sheng Li Xue Bao; 2003 Apr; 55(2):187-90. PubMed ID: 12715109
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].
Feng HS; Zang YM; Zhu MZ; Pei JM; Wang YM; Wang L; Shi PT
Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
Yamamoto K; Ikeda U; Shimada K
J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the proliferation of smooth muscle cells from human coronary bypass vessels by vasonatrin peptide.
Lu SY; Zhu MZ; Wang DS; Chen SY; Zhang WD; Dong H; Yu J; Guo HT
Physiol Res; 2004; 53(4):387-93. PubMed ID: 15311997
[TBL] [Abstract][Full Text] [Related]
18. Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.
Chen BY; Tie R; Qu P; Zhu MZ; Zhu XX; Jin J; Yu J
J Endocrinol Invest; 2011 Nov; 34(10):742-6. PubMed ID: 21625198
[TBL] [Abstract][Full Text] [Related]
19. Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis.
Nishikawa S; Tatsumi T; Shiraishi J; Matsunaga S; Takeda M; Mano A; Kobara M; Keira N; Okigaki M; Takahashi T; Matsubara H
J Mol Cell Cardiol; 2006 Apr; 40(4):510-9. PubMed ID: 16527305
[TBL] [Abstract][Full Text] [Related]
20. [Effect of AcSDKP on the proliferation and collagen synthesis in cultured rat cardiac fibroblasts stimulated by PDGF].
Zhu XL; Wang LP; Yang F; Wang RM; Ma WD; Luo L; Hu WM; Zhang LJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Feb; 23(1):66-9. PubMed ID: 21171371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
